| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |